Position in BMY
as of Jun 30, 2026
· filed Jul 28, 2026
Position Value
$2,347,496
-$274,646 QoQ
Shares Held
40,741
-5.8% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#771
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KANAWHA CAPITAL MANAGEMENT LLC holds $95,466,643 across 8 Drug Manufacturers - General names. BMY ranks #5 (2.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
148,501 | $37,714,798 | |
| 2 | ABBV |
AbbVie Inc.
|
141,643 | $35,643,044 | |
| 3 | LLY |
ELI LILLY & Co
|
8,046 | $9,650,614 | |
| 4 | PFE |
Pfizer Inc
|
290,647 | $6,998,779 | |
| 5 | BMY |
Bristol Myers Squibb Co
This page
|
40,741 | $2,347,496 | |
| 6 | MRK |
Merck & Co., Inc.
|
12,938 | $1,662,533 | |
| 7 | AMGN |
Amgen Inc
|
2,441 | $883,934 | |
| 8 | NVS |
Novartis AG
|
3,608 | $565,445 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,347,496 | 40,741 | Shares | Sole | 2026-07-28 | |
| 2026-03-31 | $2,622,142 | 43,234 | Shares | Sole | 2026-04-28 | |
| 2025-12-31 | $2,446,286 | 45,352 | Shares | Sole | 2026-01-28 | |
| 2025-09-30 | $1,583,866 | 35,119 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $1,747,493 | 37,751 | Shares | Sole | 2025-07-29 | |
| 2025-03-31 | $2,268,462 | 37,194 | Shares | Sole | 2025-04-28 | |
| 2024-12-31 | $2,048,433 | 36,217 | Shares | Sole | 2025-01-30 | |
| 2024-09-30 | $1,902,014 | 36,761 | Shares | Sole | 2024-10-29 | |
| 2024-06-30 | $1,620,002 | 39,008 | Shares | Sole | 2024-07-25 | |
| 2024-03-31 | $2,752,335 | 50,753 | Shares | Sole | 2024-04-29 | |
| 2023-12-31 | $3,135,759 | 61,114 | Shares | Sole | 2024-01-29 | |
| 2023-09-30 | $4,153,980 | 71,571 | Shares | Sole | 2023-10-26 | |
| 2023-06-30 | $4,656,966 | 72,822 | Shares | Sole | 2023-07-28 | |
| 2023-03-31 | $4,958,576 | 71,542 | Shares | Sole | 2023-05-08 | |
| 2022-12-31 | $5,138,381 | 71,416 | Shares | Sole | 2023-02-01 | |
| 2022-09-30 | $4,954,546 | 69,694 | Shares | Sole | 2022-10-31 | |
| 2022-06-30 | $5,707,086 | 74,118 | Shares | Sole | 2022-07-27 | |
| 2022-03-31 | $5,437,375 | 74,454 | Shares | Sole | 2022-04-26 | |
| 2021-12-31 | $4,846,777 | 77,735 | Shares | Sole | 2022-01-31 | |
| 2021-09-30 | $4,583,959 | 77,471 | Shares | Sole | 2021-10-28 | |
| 2021-06-30 | $5,172,202 | 77,405 | Shares | Sole | 2021-07-22 | |
| 2021-03-31 | $4,980,704 | 78,896 | Shares | Sole | 2021-04-26 | |
| 2020-12-31 | $4,841,627 | 78,053 | Shares | Sole | 2021-02-01 | |
| 2020-09-30 | $4,394,598 | 72,891 | Shares | Sole | 2020-10-29 | |
| 2020-06-30 | $4,312,215 | 73,337 | Shares | Sole | 2020-08-04 | |
| 2020-03-31 | $4,082,564 | 73,243 | Shares | Sole | 2020-05-04 | |
| No filing history on record for this holder in this stock. | ||||||